Inventory increased 39.1%
Inventory changed +39.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Inventory changed +39.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Current assets changed +47.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Total assets changed +39.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Working capital changed +54.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Free-cash-flow proxy changed +13.4% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Operating margin changed +13897 basis points from the comparable as-filed period.
Cash & equivalents changed +71.0% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Capital expenditure changed -94.2% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Revenue changed +44.8% from the comparable as-filed period.
Operating cash flow changed +8.1% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Stock-based compensation changed +65.1% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
SBC / revenue changed +284 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Gross profit changed +49.1% from the comparable as-filed period.
Operating income changed +11.7% from the comparable as-filed period.
Gross margin changed +146 basis points from the comparable as-filed period.
Capex / revenue changed -1852 basis points from the comparable as-filed period.
Cost of revenue changed +40.6% from the comparable as-filed period.
Inventory / revenue changed -718 basis points from the comparable as-filed period.
Current liabilities changed +20.5% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Free-cash-flow margin changed +12575 basis points from the comparable as-filed period.
Operating cash-flow margin changed +10723 basis points from the comparable as-filed period.
R&D / revenue changed -6943 basis points from the comparable as-filed period.
Research & development changed -14.9% from the comparable as-filed period.
Trade receivables changed -16.6% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Current ratio changed +22.6% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Receivables / revenue changed -7956 basis points from the comparable as-filed period.
Working capital / assets changed +777 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.